Detalhe da pesquisa
1.
Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical features.
Br J Cancer
; 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38849476
2.
Bridging treatment prior to chimeric antigen receptor T-cell therapy in multiple myeloma.
Br J Haematol
; 204(2): 449-454, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036424
3.
Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations.
Br J Haematol
; 204(4): 1300-1306, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291707
4.
Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma.
Br J Haematol
; 203(5): 736-746, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287117
5.
Teclistamab in patients with multiple myeloma and impaired renal function.
Am J Hematol
; 98(11): E322-E324, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614153
6.
Revisiting the impact of immunoglobulin isotypes in multiple myeloma.
Ann Hematol
; 101(4): 825-829, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138417
7.
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapy.
Am J Hematol
; 97(9): 1170-1177, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731911
8.
New regimens and directions in the management of newly diagnosed multiple myeloma.
Am J Hematol
; 96(3): 367-378, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393136
9.
Stem Cell Mobilization and Autograft Minimal Residual Disease Negativity with Novel Induction Regimens in Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(8): 1394-1401, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32442725
10.
Best practices for the assessment of measurable residual disease (MRD) in multiple myeloma.
Clin Adv Hematol Oncol
; 18 Suppl 1(1): 1-20, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33843859
11.
Challenges and opportunities in the assessment of measurable residual disease in multiple myeloma.
Br J Haematol
; 186(6): 807-819, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364160
12.
Drug class refractoriness, not number of prior lines of therapy, properly classify patients with relapsed and refractory multiple myeloma.
Br J Haematol
; 200(6): 824-827, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36649972
13.
Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma.
Am J Hematol
; 97(4): E153-E155, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045201
14.
Autologous stem cell transplantation in the age of ANDROMEDA.
Br J Haematol
; 193(5): 865-866, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829514
15.
Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myeloma.
Br J Haematol
; 195(1): e113-e116, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165783
16.
Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.
Am J Hematol
; 96(10): E396-E398, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288026
17.
The impending financial healthcare burden and ethical dilemma of systemic therapy in metastatic cancer.
J Surg Oncol
; 114(3): 323-8, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377825
18.
Age is just a number, the wrong number.
Cancer
; 126(23): 5014-5016, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965676
19.
Myocardial perfusion imaging determination using an appropriate use smartphone application.
J Nucl Cardiol
; 22(1): 66-71, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25273671
20.
Assessment of measurable residual disease (MRD) in multiple myeloma: a review of the data.
Clin Adv Hematol Oncol
; 18 Suppl 1(1): 3-10, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33843860